A little more than a century ago a diagnosis of type 1 diabetes was a death sentence. Today, thanks to extraordinary ...

Living with type 1 diabetes today is leaps and bounds easier than it was decades ago. Things are only getting better ...

An international project to create a "digital twin" of the human immune system could help scientists finally tackle grand ...

Although teplizumab doesn’t work for everyone and how much it delays progression varies, it has inspired new directions in ...

Type 1 diabetes wears many faces—an elusive autoimmune disease, a metabolic mess, a chronic condition that requires lifelong ...

An international project to create a ‘digital twin’ of the human immune system could help scientists finally tackle grand ...

An international project to create a ‘digital twin’ of the human immune system could help scientists finally tackle grand challenges such as autoimmune disorders and infectious diseases.

Israel's Betalin Therapeutics is preparing an initial public offering that will value the biotech firm between $150-170 million to fund trials for its diabetes treatment, the company's chief executive ...

Researchers at the University of Surrey are creating immune digital twins to advance personalised medicine and deliver tailored treatments ...